Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 55 entries
Sorted by: Best Match Show Resources per page
Concordance of oral HPV prevalence between patients with oropharyngeal cancer and their partners.

Infectious agents and cancer

Tsao AS, Papadimitrakopoulou V, Lin H, Guo M, Lee JJ, Holsinger FC, Hong WK, Sturgis EM.
PMID: 27123042
Infect Agent Cancer. 2016 Apr 27;11:21. doi: 10.1186/s13027-016-0066-9. eCollection 2016.

BACKGROUND: Human papilloma virus (HPV) is a known causative factor in oropharyngeal squamous cell cancer (OPC). In this prospective study, we sought to define the risk of HPV transmission between OPC patients and their sexual partners by performing HPV...

Cite
Tsao AS, Papadimitrakopoulou V, Lin H, et al. Concordance of oral HPV prevalence between patients with oropharyngeal cancer and their partners. Infect Agent Cancer. 2016;11:21doi: 10.1186/s13027-016-0066-9.
Tsao, A. S., Papadimitrakopoulou, V., Lin, H., Guo, M., Lee, J. J., Holsinger, F. C., Hong, W. K., & Sturgis, E. M. (2016). Concordance of oral HPV prevalence between patients with oropharyngeal cancer and their partners. Infectious agents and cancer, 1121. https://doi.org/10.1186/s13027-016-0066-9
Tsao, Anne S, et al. "Concordance of oral HPV prevalence between patients with oropharyngeal cancer and their partners." Infectious agents and cancer vol. 11 (2016): 21. doi: https://doi.org/10.1186/s13027-016-0066-9
Tsao AS, Papadimitrakopoulou V, Lin H, Guo M, Lee JJ, Holsinger FC, Hong WK, Sturgis EM. Concordance of oral HPV prevalence between patients with oropharyngeal cancer and their partners. Infect Agent Cancer. 2016 Apr 27;11:21. doi: 10.1186/s13027-016-0066-9. eCollection 2016. PMID: 27123042; PMCID: PMC4847345.
Copy Download .nbib Format: NLM
Non-Small Cell Lung Cancer beyond Biomarkers: The Evolving Landscape of Clinical Trial Design.

Journal of personalized medicine

Dimou A, Papadimitrakopoulou V.
PMID: 25563357
J Pers Med. 2014 Jun 30;4(3):386-401. doi: 10.3390/jpm4030386.

The approval of EGFR and ALK directed tyrosine kinase inhibitors materialized the concept of tailoring therapy on the basis of specific biomarkers for treating patients with NSCLC. Research for other biologics, although demonstrating clinical benefit, has been less successful...

Cite
Dimou A, Papadimitrakopoulou V. Non-Small Cell Lung Cancer beyond Biomarkers: The Evolving Landscape of Clinical Trial Design. J Pers Med. 2014;4(3):386-401doi: 10.3390/jpm4030386.
Dimou, A., & Papadimitrakopoulou, V. (2014). Non-Small Cell Lung Cancer beyond Biomarkers: The Evolving Landscape of Clinical Trial Design. Journal of personalized medicine, 4(3), 386-401. https://doi.org/10.3390/jpm4030386
Dimou, Anastasios, and Papadimitrakopoulou, Vassiliki. "Non-Small Cell Lung Cancer beyond Biomarkers: The Evolving Landscape of Clinical Trial Design." Journal of personalized medicine vol. 4,3 (2014): 386-401. doi: https://doi.org/10.3390/jpm4030386
Dimou A, Papadimitrakopoulou V. Non-Small Cell Lung Cancer beyond Biomarkers: The Evolving Landscape of Clinical Trial Design. J Pers Med. 2014 Jun 30;4(3):386-401. doi: 10.3390/jpm4030386. PMID: 25563357; PMCID: PMC4263964.
Copy Download .nbib Format: NLM
Length separation of Zwitterion-functionalized single wall carbon nanotubes by GPC.

Journal of the American Chemical Society

Chattopadhyay D, Lastella S, Kim S, Papadimitrakopoulos F.
PMID: 11817929
J Am Chem Soc. 2002 Feb 06;124(5):728-9. doi: 10.1021/ja0172159.

The length-fractionation of shortened (250 to 25 nm), zwitterion-functionalized, single wall carbon nanotubes (SWNTs) has been demonstrated via gel permeation chromatography (GPC). The UV-Vis spectrum of each fraction indicates an apparent "solubilization", as evident by the direct observation of...

Cite
Chattopadhyay D, Lastella S, Kim S, et al. Length separation of Zwitterion-functionalized single wall carbon nanotubes by GPC. J Am Chem Soc. 2002;124(5):728-9doi: 10.1021/ja0172159.
Chattopadhyay, D., Lastella, S., Kim, S., & Papadimitrakopoulos, F. (2002). Length separation of Zwitterion-functionalized single wall carbon nanotubes by GPC. Journal of the American Chemical Society, 124(5), 728-9. https://doi.org/10.1021/ja0172159
Chattopadhyay, Debjit, et al. "Length separation of Zwitterion-functionalized single wall carbon nanotubes by GPC." Journal of the American Chemical Society vol. 124,5 (2002): 728-9. doi: https://doi.org/10.1021/ja0172159
Chattopadhyay D, Lastella S, Kim S, Papadimitrakopoulos F. Length separation of Zwitterion-functionalized single wall carbon nanotubes by GPC. J Am Chem Soc. 2002 Feb 06;124(5):728-9. doi: 10.1021/ja0172159. PMID: 11817929.
Copy Download .nbib Format: NLM
Ligand exchange dynamics in aluminum tris-(quinoline-8-olate): a solution state NMR study.

Journal of the American Chemical Society

Utz M, Chen C, Morton M, Papadimitrakopoulos F.
PMID: 12553840
J Am Chem Soc. 2003 Feb 05;125(5):1371-5. doi: 10.1021/ja027825o.

The exchange kinetics between the three symmetry-inequivalent ligands in the meridianal isomer of aluminum tris-(quinoline-8-olate) (Alq(3)), a widely used electron-transporting and light-emitting material in the field of organic light emitting diodes, have been studied using two-dimensional exchange NMR spectroscopy...

Cite
Utz M, Chen C, Morton M, et al. Ligand exchange dynamics in aluminum tris-(quinoline-8-olate): a solution state NMR study. J Am Chem Soc. 2003;125(5):1371-5doi: 10.1021/ja027825o.
Utz, M., Chen, C., Morton, M., & Papadimitrakopoulos, F. (2003). Ligand exchange dynamics in aluminum tris-(quinoline-8-olate): a solution state NMR study. Journal of the American Chemical Society, 125(5), 1371-5. https://doi.org/10.1021/ja027825o
Utz, Marcel, et al. "Ligand exchange dynamics in aluminum tris-(quinoline-8-olate): a solution state NMR study." Journal of the American Chemical Society vol. 125,5 (2003): 1371-5. doi: https://doi.org/10.1021/ja027825o
Utz M, Chen C, Morton M, Papadimitrakopoulos F. Ligand exchange dynamics in aluminum tris-(quinoline-8-olate): a solution state NMR study. J Am Chem Soc. 2003 Feb 05;125(5):1371-5. doi: 10.1021/ja027825o. PMID: 12553840.
Copy Download .nbib Format: NLM
(n,m) Abundance evaluation of single-walled carbon nanotubes by fluorescence and absorption spectroscopy.

Journal of the American Chemical Society

Luo Z, Pfefferle LD, Haller GL, Papadimitrakopoulos F.
PMID: 17132018
J Am Chem Soc. 2006 Dec 06;128(48):15511-6. doi: 10.1021/ja0657096.

A methodology that takes into account the (n,m) structure of single-walled carbon nanotubes (SWNTs), through an exciton-exciton resonance model and an electron-phonon interaction model, was employed in order to evaluate the semiconducting (n,m) abundance of two SWNT samples (i.e.,...

Cite
Luo Z, Pfefferle LD, Haller GL, et al. (n,m) Abundance evaluation of single-walled carbon nanotubes by fluorescence and absorption spectroscopy. J Am Chem Soc. 2006;128(48):15511-6doi: 10.1021/ja0657096.
Luo, Z., Pfefferle, L. D., Haller, G. L., & Papadimitrakopoulos, F. (2006). (n,m) Abundance evaluation of single-walled carbon nanotubes by fluorescence and absorption spectroscopy. Journal of the American Chemical Society, 128(48), 15511-6. https://doi.org/10.1021/ja0657096
Luo, Zhengtang, et al. "(n,m) Abundance evaluation of single-walled carbon nanotubes by fluorescence and absorption spectroscopy." Journal of the American Chemical Society vol. 128,48 (2006): 15511-6. doi: https://doi.org/10.1021/ja0657096
Luo Z, Pfefferle LD, Haller GL, Papadimitrakopoulos F. (n,m) Abundance evaluation of single-walled carbon nanotubes by fluorescence and absorption spectroscopy. J Am Chem Soc. 2006 Dec 06;128(48):15511-6. doi: 10.1021/ja0657096. PMID: 17132018.
Copy Download .nbib Format: NLM
Layer-by-layer assembled semipermeable membrane for amperometric glucose sensors.

Journal of diabetes science and technology

Tipnis R, Vaddiraju S, Jain F, Burgess DJ, Papadimitrakopoulos F.
PMID: 19888406
J Diabetes Sci Technol. 2007 Mar;1(2):193-200. doi: 10.1177/193229680700100209.

BACKGROUND: The performance of implantable glucose sensors is closely related to the behavior of the outer membrane. Such membranes govern the diffusion characteristics of glucose and, correspondingly, the sensitivity of the sensors. This manuscript discusses the selection of various...

Cite
Tipnis R, Vaddiraju S, Jain F, et al. Layer-by-layer assembled semipermeable membrane for amperometric glucose sensors. J Diabetes Sci Technol. 2007;1(2):193-200doi: 10.1177/193229680700100209.
Tipnis, R., Vaddiraju, S., Jain, F., Burgess, D. J., & Papadimitrakopoulos, F. (2007). Layer-by-layer assembled semipermeable membrane for amperometric glucose sensors. Journal of diabetes science and technology, 1(2), 193-200. https://doi.org/10.1177/193229680700100209
Tipnis, Ritesh, et al. "Layer-by-layer assembled semipermeable membrane for amperometric glucose sensors." Journal of diabetes science and technology vol. 1,2 (2007): 193-200. doi: https://doi.org/10.1177/193229680700100209
Tipnis R, Vaddiraju S, Jain F, Burgess DJ, Papadimitrakopoulos F. Layer-by-layer assembled semipermeable membrane for amperometric glucose sensors. J Diabetes Sci Technol. 2007 Mar;1(2):193-200. doi: 10.1177/193229680700100209. PMID: 19888406; PMCID: PMC2771465.
Copy Download .nbib Format: NLM
Dielectrophoretic assembly of grain-boundary-free 2D colloidal single crystals.

Journal of colloid and interface science

Kim S, Asmatulu R, Marcus HL, Papadimitrakopoulos F.
PMID: 21144531
J Colloid Interface Sci. 2011 Feb 15;354(2):448-54. doi: 10.1016/j.jcis.2010.11.023. Epub 2010 Dec 07.

Dielectrophoresis (DEP) force-assisted assembly of a colloidal single photonic-crystal monolayer in a microfluidic chamber was demonstrated. Negative DEP force with a high-frequency AC electric field induced the compression of colloidal microspheres to form a colloidal crystal domain at the...

Cite
Kim S, Asmatulu R, Marcus HL, et al. Dielectrophoretic assembly of grain-boundary-free 2D colloidal single crystals. J Colloid Interface Sci. 2010;354(2):448-54doi: 10.1016/j.jcis.2010.11.023.
Kim, S., Asmatulu, R., Marcus, H. L., & Papadimitrakopoulos, F. (2011). Dielectrophoretic assembly of grain-boundary-free 2D colloidal single crystals. Journal of colloid and interface science, 354(2), 448-54. https://doi.org/10.1016/j.jcis.2010.11.023
Kim, Sejong, et al. "Dielectrophoretic assembly of grain-boundary-free 2D colloidal single crystals." Journal of colloid and interface science vol. 354,2 (2011): 448-54. doi: https://doi.org/10.1016/j.jcis.2010.11.023
Kim S, Asmatulu R, Marcus HL, Papadimitrakopoulos F. Dielectrophoretic assembly of grain-boundary-free 2D colloidal single crystals. J Colloid Interface Sci. 2011 Feb 15;354(2):448-54. doi: 10.1016/j.jcis.2010.11.023. Epub 2010 Dec 07. PMID: 21144531.
Copy Download .nbib Format: NLM
Nanomaterials and biomaterials in electrochemical arrays for protein detection.

Journal of materials chemistry. B

Rusling JF, Bishop GW, Doan N, Papadimitrakopoulos F.
PMID: 24392222
J Mater Chem B. 2014 Jan 07;2(1). doi: 10.1039/C3TB21323D.

Nanomaterials and biomaterials are important components of new electrochemical arrays designed for sensitive detection of proteins in biological fluids. Such multiplexed protein arrays are predicted to have an important future in personalized medical diagnostics, especially for cancer and heart...

Cite
Rusling JF, Bishop GW, Doan N, et al. Nanomaterials and biomaterials in electrochemical arrays for protein detection. J Mater Chem B. 2014;2(1)doi: 10.1039/C3TB21323D.
Rusling, J. F., Bishop, G. W., Doan, N., & Papadimitrakopoulos, F. (2014). Nanomaterials and biomaterials in electrochemical arrays for protein detection. Journal of materials chemistry. B, 2(1), . https://doi.org/10.1039/C3TB21323D
Rusling, James F, et al. "Nanomaterials and biomaterials in electrochemical arrays for protein detection." Journal of materials chemistry. B vol. 2,1 (2014). doi: https://doi.org/10.1039/C3TB21323D
Rusling JF, Bishop GW, Doan N, Papadimitrakopoulos F. Nanomaterials and biomaterials in electrochemical arrays for protein detection. J Mater Chem B. 2014 Jan 07;2(1). doi: 10.1039/C3TB21323D. PMID: 24392222; PMCID: PMC3878175.
Copy Download .nbib Format: NLM
Defect quenching of conjugated polymer luminescence.

Physical review letters

Galvin ME, Miller TM, Papadimitrakopoulos F, Rothberg LJ, Yan M.
PMID: 10057526
Phys Rev Lett. 1994 Aug 01;73(5):744-747. doi: 10.1103/PhysRevLett.73.744.

No abstract available.

Cite
Galvin ME, Miller TM, Papadimitrakopoulos F, et al. Defect quenching of conjugated polymer luminescence. Phys Rev Lett. 1994;73(5):744-747doi: 10.1103/PhysRevLett.73.744.
Galvin, M. E., Miller, T. M., Papadimitrakopoulos, F., Rothberg, L. J., & Yan, M. (1994). Defect quenching of conjugated polymer luminescence. Physical review letters, 73(5), 744-747. https://doi.org/10.1103/PhysRevLett.73.744
Galvin, et al. "Defect quenching of conjugated polymer luminescence." Physical review letters vol. 73,5 (1994): 744-747. doi: https://doi.org/10.1103/PhysRevLett.73.744
Galvin ME, Miller TM, Papadimitrakopoulos F, Rothberg LJ, Yan M. Defect quenching of conjugated polymer luminescence. Phys Rev Lett. 1994 Aug 01;73(5):744-747. doi: 10.1103/PhysRevLett.73.744. PMID: 10057526.
Copy Download .nbib Format: NLM
Author Correction: Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer.

Nature medicine

Deribe YL, Sun Y, Terranova C, Khan F, Martinez-Ledesma J, Gay J, Gao G, Mullinax RA, Khor T, Feng N, Lin YH, Wu CC, Reyes C, Peng Q, Robinson F, Inoue A, Kochat V, Liu CG, Asara JM, Moran C, Muller F, Wang J, Fang B, Papadimitrakopoulou V, Wistuba II, Rai K, Marszalek J, Futreal PA.
PMID: 30104769
Nat Med. 2018 Oct;24(10):1627. doi: 10.1038/s41591-018-0173-9.

In the version of this article originally published, information regarding several funding sources was omitted from the Acknowledgements section. The following sentences should have been included: "This work was supported by the generous philanthropic contributions to The University of...

Cite
Deribe YL, Sun Y, Terranova C, et al. Author Correction: Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer. Nat Med. 2018;24(10):1627doi: 10.1038/s41591-018-0173-9.
Deribe, Y. L., Sun, Y., Terranova, C., Khan, F., Martinez-Ledesma, J., Gay, J., Gao, G., Mullinax, R. A., Khor, T., Feng, N., Lin, Y. H., Wu, C. C., Reyes, C., Peng, Q., Robinson, F., Inoue, A., Kochat, V., Liu, C. G., Asara, J. M., Moran, C., Muller, F., Wang, J., Fang, B., Papadimitrakopoulou, V., Wistuba, I. I., Rai, K., Marszalek, J., & Futreal, P. A. (2018). Author Correction: Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer. Nature medicine, 24(10), 1627. https://doi.org/10.1038/s41591-018-0173-9
Deribe, Yonathan Lissanu, et al. "Author Correction: Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer." Nature medicine vol. 24,10 (2018): 1627. doi: https://doi.org/10.1038/s41591-018-0173-9
Deribe YL, Sun Y, Terranova C, Khan F, Martinez-Ledesma J, Gay J, Gao G, Mullinax RA, Khor T, Feng N, Lin YH, Wu CC, Reyes C, Peng Q, Robinson F, Inoue A, Kochat V, Liu CG, Asara JM, Moran C, Muller F, Wang J, Fang B, Papadimitrakopoulou V, Wistuba II, Rai K, Marszalek J, Futreal PA. Author Correction: Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer. Nat Med. 2018 Oct;24(10):1627. doi: 10.1038/s41591-018-0173-9. PMID: 30104769.
Copy Download .nbib Format: NLM
Phase 2 Study of Talazoparib in Patients With Homologous Recombination Repair-Deficient Squamous Cell Lung Cancer: Lung-MAP Substudy S1400G.

Clinical lung cancer

Owonikoko TK, Redman MW, Byers LA, Hirsch FR, Mack PC, Schwartz LH, Bradley JD, Stinchcombe TE, Leighl NB, Al Baghdadi T, Lara P, Miao J, Kelly K, Ramalingam SS, Herbst RS, Papadimitrakopoulou V, Gandara DR.
PMID: 33583720
Clin Lung Cancer. 2021 May;22(3):187-194.e1. doi: 10.1016/j.cllc.2021.01.001. Epub 2021 Jan 10.

PURPOSE: This signal finding study (S1400G) was designed to evaluate the efficacy of talazoparib in advanced stage squamous cell lung cancer harboring homologous recombination repair deficiency.PATIENTS AND METHODS: The full eligible population (FEP) had tumors with a deleterious mutation...

Cite
Owonikoko TK, Redman MW, Byers LA, et al. Phase 2 Study of Talazoparib in Patients With Homologous Recombination Repair-Deficient Squamous Cell Lung Cancer: Lung-MAP Substudy S1400G. Clin Lung Cancer. 2021;22(3):187-194.e1doi: 10.1016/j.cllc.2021.01.001.
Owonikoko, T. K., Redman, M. W., Byers, L. A., Hirsch, F. R., Mack, P. C., Schwartz, L. H., Bradley, J. D., Stinchcombe, T. E., Leighl, N. B., Al Baghdadi, T., Lara, P., Miao, J., Kelly, K., Ramalingam, S. S., Herbst, R. S., Papadimitrakopoulou, V., & Gandara, D. R. (2021). Phase 2 Study of Talazoparib in Patients With Homologous Recombination Repair-Deficient Squamous Cell Lung Cancer: Lung-MAP Substudy S1400G. Clinical lung cancer, 22(3), 187-194.e1. https://doi.org/10.1016/j.cllc.2021.01.001
Owonikoko, Taofeek K, et al. "Phase 2 Study of Talazoparib in Patients With Homologous Recombination Repair-Deficient Squamous Cell Lung Cancer: Lung-MAP Substudy S1400G." Clinical lung cancer vol. 22,3 (2021): 187-194.e1. doi: https://doi.org/10.1016/j.cllc.2021.01.001
Owonikoko TK, Redman MW, Byers LA, Hirsch FR, Mack PC, Schwartz LH, Bradley JD, Stinchcombe TE, Leighl NB, Al Baghdadi T, Lara P, Miao J, Kelly K, Ramalingam SS, Herbst RS, Papadimitrakopoulou V, Gandara DR. Phase 2 Study of Talazoparib in Patients With Homologous Recombination Repair-Deficient Squamous Cell Lung Cancer: Lung-MAP Substudy S1400G. Clin Lung Cancer. 2021 May;22(3):187-194.e1. doi: 10.1016/j.cllc.2021.01.001. Epub 2021 Jan 10. PMID: 33583720; PMCID: PMC8637652.
Copy Download .nbib Format: NLM
SWOG S1400A (NCT02154490): A Phase II Study of Durvalumab for Patients With Previously Treated Stage IV or Recurrent Squamous Cell Lung Cancer (Lung-MAP Sub-study).

Clinical lung cancer

Borghaei H, Redman MW, Kelly K, Waqar SN, Robert F, Kiefer GJ, Stella PJ, Minichiello K, Gandara DR, Herbst RS, Papadimitrakopoulou VA.
PMID: 33358401
Clin Lung Cancer. 2021 May;22(3):178-186. doi: 10.1016/j.cllc.2020.10.015. Epub 2020 Nov 10.

INTRODUCTION: The objective of the Lung-MAP sub-study S1400A was to evaluate the response rate to durvalumab, an anti-programmed death-ligand 1 (PD-L1) antibody, in patients with squamous non-small-cell lung cancer (SqNSCLC).PATIENTS AND METHODS: Patients who progressed on at least 1...

Cite
Borghaei H, Redman MW, Kelly K, et al. SWOG S1400A (NCT02154490): A Phase II Study of Durvalumab for Patients With Previously Treated Stage IV or Recurrent Squamous Cell Lung Cancer (Lung-MAP Sub-study). Clin Lung Cancer. 2020;22(3):178-186doi: 10.1016/j.cllc.2020.10.015.
Borghaei, H., Redman, M. W., Kelly, K., Waqar, S. N., Robert, F., Kiefer, G. J., Stella, P. J., Minichiello, K., Gandara, D. R., Herbst, R. S., & Papadimitrakopoulou, V. A. (2021). SWOG S1400A (NCT02154490): A Phase II Study of Durvalumab for Patients With Previously Treated Stage IV or Recurrent Squamous Cell Lung Cancer (Lung-MAP Sub-study). Clinical lung cancer, 22(3), 178-186. https://doi.org/10.1016/j.cllc.2020.10.015
Borghaei, Hossein, et al. "SWOG S1400A (NCT02154490): A Phase II Study of Durvalumab for Patients With Previously Treated Stage IV or Recurrent Squamous Cell Lung Cancer (Lung-MAP Sub-study)." Clinical lung cancer vol. 22,3 (2021): 178-186. doi: https://doi.org/10.1016/j.cllc.2020.10.015
Borghaei H, Redman MW, Kelly K, Waqar SN, Robert F, Kiefer GJ, Stella PJ, Minichiello K, Gandara DR, Herbst RS, Papadimitrakopoulou VA. SWOG S1400A (NCT02154490): A Phase II Study of Durvalumab for Patients With Previously Treated Stage IV or Recurrent Squamous Cell Lung Cancer (Lung-MAP Sub-study). Clin Lung Cancer. 2021 May;22(3):178-186. doi: 10.1016/j.cllc.2020.10.015. Epub 2020 Nov 10. PMID: 33358401.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 55 entries